Osimertinib in EGFR-Mutated Advanced NSCLC
N Engl J Med
.
2020 May 7;382(19):1863-1864.
doi: 10.1056/NEJMc2001514.
Author
Martin S Staege
1
Affiliation
1
Martin Luther University Halle-Wittenberg, Halle (Saale), Germany martin.staege@uk-halle.de.
PMID:
32374971
DOI:
10.1056/NEJMc2001514
No abstract available
Publication types
Letter
Comment
MeSH terms
Acrylamides
Aniline Compounds
Carcinoma, Non-Small-Cell Lung*
ErbB Receptors
Humans
Lung Neoplasms*
Substances
Acrylamides
Aniline Compounds
osimertinib
EGFR protein, human
ErbB Receptors